Abstract
Patients who received resection for pancreatic adenocarcinoma (PC) after preoperative chemoradiotherapy (CRT) with gemcitabine (GEM) were reportedly benefited histopathologically. The purpose of the present study was to evaluate the correlation between histopathological effects (HE) and treatment parameters (radiation dose and cumulated GEM dose) of preoperative CRT for PC.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
